Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Astaxanthin-loaded brain-permeable liposomes for Parkinson’s disease treatment via antioxidant and anti-inflammatory responses

Fig. 1

Optimization of ASX encapsulation and characterization of LPs. (A) Schematic diagram of Lf-ASX-LP preparation. EE and LC of ASX-LPs were measured under varying (B) ASX-to-lipid ratios and (C) lipid compositions. (D) Concentration of conjugated Lf on LPs under varying initial concentrations of Lf. (E) Average particle size, PDI, and (F) zeta potential of each formulation. (G) Topographic images of Lf-ASX-LPs obtained by AFM

Back to article page